Xu ZY - Search Results

1

Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit.

Zhao JD, Xu ZY, Zhu J, Qiu JJ, Hu WG, Cheng LF, Zhang XJ, Jiang GL. Zhao JD, et al. Among authors: xu zy. Radiother Oncol. 2008 Jun;87(3):439-44. doi: 10.1016/j.radonc.2007.12.006. Epub 2008 Mar 10. Radiother Oncol. 2008. PMID: 18334274

2

Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.

Xu ZY, Liang SX, Zhu J, Zhu XD, Zhao JD, Lu HJ, Yang YL, Chen L, Wang AY, Fu XL, Jiang GL. Xu ZY, et al. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):189-95. doi: 10.1016/j.ijrobp.2005.11.034. Epub 2006 Mar 20. Int J Radiat Oncol Biol Phys. 2006. PMID: 16542787

3

Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.

Liang SX, Zhu XD, Xu ZY, Zhu J, Zhao JD, Lu HJ, Yang YL, Chen L, Wang AY, Fu XL, Jiang GL. Liang SX, et al. Among authors: xu zy. Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):426-34. doi: 10.1016/j.ijrobp.2005.12.031. Int J Radiat Oncol Biol Phys. 2006. PMID: 16690430

4

Three-dimensional conformal radiation therapy for squamous cell carcinoma of the esophagus: a prospective phase I/II study.

Wu KL, Chen GY, Xu ZY, Fu XL, Qian H, Jiang GL. Wu KL, et al. Among authors: xu zy. Radiother Oncol. 2009 Dec;93(3):454-7. doi: 10.1016/j.radonc.2009.10.014. Epub 2009 Nov 16. Radiother Oncol. 2009. PMID: 19919886 Clinical Trial.

5

Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.

Zhao JD, Liu J, Ren ZG, Gu K, Zhou ZH, Li WT, Chen Z, Xu ZY, Liu LM, Jiang GL. Zhao JD, et al. Among authors: xu zy. Radiat Oncol. 2010 Feb 12;5:12. doi: 10.1186/1748-717X-5-12. Radiat Oncol. 2010. PMID: 20149262 Free PMC article. Clinical Trial.

6

Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study.

Ren ZG, Zhao JD, Gu K, Chen Z, Lin JH, Xu ZY, Hu WG, Zhou ZH, Liu LM, Jiang GL. Ren ZG, et al. Among authors: xu zy. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):496-502. doi: 10.1016/j.ijrobp.2009.10.070. Epub 2010 Apr 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 20421145

7

Use of combined maximum and minimum intensity projections to determine internal target volume in 4-dimensional CT scans for hepatic malignancies.

Liu J, Wang JZ, Zhao JD, Xu ZY, Jiang GL. Liu J, et al. Among authors: xu zy. Radiat Oncol. 2012 Jan 30;7:11. doi: 10.1186/1748-717X-7-11. Radiat Oncol. 2012. PMID: 22284745 Free PMC article.

8

Constraints for symptomatic radiation pneumonitis of helical tomotherapy hypofractionated simultaneous multitarget radiotherapy for pulmonary metastasis from hepatocellular carcinoma.

Lin G, Xiao H, Zeng Z, Xu Z, He J, Sun T, Liu J, Guo G, Ji W, Hu Y. Lin G, et al. Radiother Oncol. 2017 May;123(2):246-250. doi: 10.1016/j.radonc.2017.02.015. Epub 2017 Mar 14. Radiother Oncol. 2017. PMID: 28314468

9

Evaluation of IGRT-Induced Imaging Doses and Secondary Cancer Risk for SBRT Early Lung Cancer Patients In Silico Study.

Duan YH, Gu HL, Yang XH, Chen H, Wang H, Shao Y, Li XY, Feng AH, Ying YC, Fu XL, Ma K, Zhou T, Xu ZY. Duan YH, et al. Among authors: xu zy. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211016472. doi: 10.1177/15330338211016472. Technol Cancer Res Treat. 2021. PMID: 34184567 Free PMC article.

10

Deep Learning for Patient-Specific Quality Assurance: Predicting Gamma Passing Rates for IMRT Based on Delivery Fluence Informed by log Files.

Huang Y, Pi Y, Ma K, Miao X, Fu S, Zhu Z, Cheng Y, Zhang Z, Chen H, Wang H, Gu H, Shao Y, Duan Y, Feng A, Zhuo W, Xu Z. Huang Y, et al. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221104881. doi: 10.1177/15330338221104881. Technol Cancer Res Treat. 2022. PMID: 35726209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

961 results

Search Page

Filters